New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2014
07:18 EDTAMAGAMAG Pharmaceuticals reports Q4 EPS (17c), consensus (10c)
Reports Q4 revenue $21.71M, consensus $21.01M.
News For AMAG From The Last 14 Days
Check below for free stories on AMAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
09:55 EDTAMAGAMAG Pharmaceuticals upgraded to Buy from Hold at Jefferies
08:21 EDTAMAGAMAG Pharmaceuticals price target raised to $45 from $28 at RW Baird
Baird raised its price target on AMAG Pharmaceuticals to $45 from $28 following the company's announced acquisition of Makena, the flagship product of Lumara Health. The firm said the deal provides P&L leverage and a favorable set-up for new money. Baird reiterates its Outperform rating on AMAG Pharmaceuticals.
08:11 EDTAMAGAMAG Pharmaceuticals upgraded to Outperform at FBR Capital
Subscribe for More Information
06:45 EDTAMAGAMAG Pharmaceuticals upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
September 29, 2014
07:17 EDTAMAGLumara Health to be acquired in two separate transactions for $1.11B
Subscribe for More Information
07:16 EDTAMAGAMAG Pharmaceuticals to host conference call
Conference call to discuss a definitive agreement to acquire Lumara Health Inc will be held at 8 am on September 29. Webcast Link
06:59 EDTAMAGAMAG Pharmaceuticals to acquire Lumara Health for $675M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use